|
|
| Research article summary (published 19 Mar 2007): |
Clinical outcome measures in multiple sclerosis.
Full Abstract
Quantifying the clinical impact of multiple sclerosis (MS) is a critical issue for judging experimental therapies tested in clinical trials, and, in everyday practice, for optimizing individual patient care. Proposed clinical outcome measures for MS belong to four main categories. In the first, information is based on the objective neurological examination. Examples in this category include the Expanded Disability Status Scale and related instruments, the Scripps Neurological Rating Scale and the MS Impairment Scale. The second category is represented by quantitative tests of neurological function:
the most important example is represented by the Multiple Sclerosis Functional Composite. In the third category, information is provided by the patient or a family member. Measures of disability and handicap (as the Incapacity Status Scale, and the Environmental Status Scale), and generic or disease-specific quality of life instruments are included in this class. Finally, the last category consists of measures which present hybrid characteristics, such as the Ambulation Index and the Cambridge Multiple Sclerosis Basic Score. To date, no single measure has emerged as the ideal outcome measure:
the main advantages and disadvantages of currently available measurement tools are discussed.
Learn Faster Today Improve your study skills
Author information
Author/s: Amato, Maria Pia (MP); Portaccio, Emilio (E);
Affiliation: Department of Neurology, University of Florence, Florence, Italy. mariapia.amato(-atsign-)unifi.it
Journal and publication information
Publication Type: Journal Article; Review
Journal: Journal of the neurological sciences (J Neurol Sci), published in Netherlands. (Language: eng)
Reference: 2007-Aug; vol 259 (issue 1-2) : pp 118-22
Dates: Created 2007/07/16; Completed 2007/10/03; Revised 2007/11/15;
PMID: 17376487, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
Related articles
These are the highest related articles currently in the database:
- The reliability and validity of pain interference measures in persons with multiple sclerosis.
30 Aug 2006 - [Diagnosis and pharmacological treatment of multiple sclerosis]
30 May 2007 - [Magnetic resonance in the diagnosis and treatment of multiple sclerosis]
30 Jul 2000 - Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups.
30 Dec 2000 - MRI, monosclerosis, and multiple sclerosis.
18 Apr 2002 - A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models.
30 Dec 2001 - Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
30 Jan 2004 - [Health care costs of multiple sclerosis in Austria. Cross-sectional study including consideration of quality of life]
29 Sep 2004 - Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis.
30 Oct 2004 - A tangled web: don't miss multiple sclerosis.
30 Oct 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.